Pancreatic Cancer Incidence and Mortality by Year, Kings County (Brooklyn), 1976-2020

Source: New York State Cancer Registry

Year of Diagnosis/Death Incidence Mortality
Males and Females Males Females Males and Females Males Females
Cases Rate per 100,000 Population 95% CI Cases Rate per 100,000 Males 95% CI Cases Rate per 100,000 Females 95% CI Deaths Rate per 100,000 Population 95% CI Deaths Rate per 100,000 Males 95% CI Deaths Rate per 100,000 Females 95% CI
1976 289 13.2 11.6-14.9 133 14.1 11.7-16.9 156 12.4 10.5-14.6 250 11.3 9.9-12.9 111 11.5 9.3-13.9 139 11.1 9.2-13.2
1977 307 14.3 12.6-16.0 147 16.7 13.9-19.8 160 12.6 10.7-14.8 302 14.2 12.6-16.0 149 17.5 14.6-20.8 153 12.0 10.2-14.2
1978 293 13.5 12.0-15.2 141 15.7 13.0-18.6 152 12.0 10.1-14.1 259 11.9 10.5-13.5 124 14.1 11.5-17.0 135 10.4 8.7-12.4
1979 282 13.1 11.5-14.7 128 14.1 11.7-16.8 154 12.2 10.3-14.3 275 12.9 11.3-14.5 132 14.9 12.3-17.8 143 11.4 9.6-13.5
1980 295 13.7 12.1-15.4 155 17.9 15.1-21.1 140 10.9 9.1-12.9 254 11.8 10.4-13.4 133 15.4 12.8-18.4 121 9.5 7.8-11.4
1981 279 13.2 11.6-14.9 145 17.2 14.4-20.4 134 10.5 8.7-12.5 271 12.6 11.1-14.2 132 15.2 12.6-18.1 139 10.8 9.0-12.8
1982 280 13.2 11.7-14.9 126 15.3 12.6-18.3 154 11.8 10.0-13.8 234 11.3 9.8-12.8 116 14.7 12.0-17.8 118 9.2 7.6-11.0
1983 294 13.7 12.1-15.4 124 14.7 12.2-17.7 170 12.9 11.0-15.1 266 12.4 10.9-14.0 128 15.4 12.7-18.4 138 10.4 8.7-12.3
1984 302 13.8 12.2-15.4 149 17.4 14.6-20.5 153 11.4 9.6-13.4 242 11.1 9.7-12.6 120 13.9 11.4-16.7 122 9.2 7.6-11.0
1985 276 12.9 11.4-14.5 125 14.9 12.3-17.8 151 11.4 9.6-13.4 228 10.5 9.2-12.0 106 12.5 10.2-15.2 122 9.1 7.5-10.9
1986 265 12.3 10.8-13.9 117 13.8 11.4-16.7 148 11.1 9.4-13.1 244 11.2 9.9-12.8 94 11.1 8.9-13.7 150 11.2 9.4-13.1
1987 280 12.8 11.3-14.4 131 15.7 13.0-18.7 149 10.9 9.2-12.8 233 10.6 9.3-12.1 121 14.3 11.8-17.2 112 8.3 6.8-10.0
1988 260 12.1 10.7-13.7 106 13.2 10.8-16.1 154 11.5 9.7-13.5 237 11.0 9.6-12.5 119 14.5 12.0-17.4 118 8.8 7.2-10.5
1989 259 12.3 10.8-13.9 120 14.4 11.8-17.2 139 10.7 9.0-12.7 245 11.4 10.0-13.0 99 11.9 9.6-14.5 146 10.9 9.2-12.9
1990 248 11.8 10.4-13.4 114 14.4 11.8-17.3 134 10.5 8.8-12.5 212 10.1 8.8-11.6 100 12.8 10.4-15.6 112 8.5 7.0-10.3
1991 261 12.3 10.9-13.9 118 14.3 11.8-17.2 143 10.9 9.2-12.8 224 10.5 9.1-11.9 110 13.2 10.8-16.0 114 8.7 7.2-10.5
1992 281 13.3 11.8-14.9 128 15.5 12.9-18.5 153 11.8 10.0-13.8 222 10.4 9.1-11.9 96 11.4 9.2-13.9 126 9.7 8.0-11.5
1993 272 12.8 11.4-14.5 116 13.9 11.4-16.7 156 12.0 10.2-14.1 242 11.5 10.0-13.0 109 13.5 11.0-16.3 133 10.3 8.6-12.2
1994 318 15.1 13.5-16.9 137 16.8 14.0-19.9 181 13.9 11.9-16.0 255 12.1 10.6-13.7 107 13.4 10.9-16.2 148 11.3 9.6-13.3
1995 238 11.2 9.9-12.8 102 12.7 10.3-15.4 136 10.4 8.7-12.3 214 10.1 8.8-11.6 98 12.3 9.9-15.0 116 8.9 7.3-10.6
1996 284 13.4 11.9-15.1 121 15.0 12.4-17.9 163 12.5 10.6-14.6 247 11.7 10.3-13.3 106 13.4 10.9-16.2 141 10.8 9.1-12.7
1997 253 11.8 10.4-13.3 117 14.1 11.7-17.0 136 10.4 8.7-12.3 218 10.2 8.9-11.7 91 11.1 8.9-13.7 127 9.7 8.1-11.5
1998 276 12.8 11.3-14.4 116 13.7 11.3-16.4 160 12.1 10.3-14.2 224 10.4 9.1-11.8 89 10.8 8.7-13.3 135 10.2 8.6-12.1
1999 275 12.4 11.0-13.9 135 15.6 13.1-18.5 140 10.4 8.7-12.2 222 10.0 8.8-11.4 103 11.8 9.6-14.4 119 8.8 7.3-10.6
2000 290 12.8 11.4-14.4 128 14.5 12.1-17.2 162 11.7 10.0-13.6 227 10.0 8.8-11.4 101 11.4 9.3-13.9 126 8.9 7.4-10.6
2001 281 12.3 10.9-13.8 110 12.4 10.1-14.9 171 12.3 10.5-14.3 252 11.0 9.7-12.5 101 11.6 9.4-14.1 151 10.8 9.1-12.6
2002 285 12.3 11.0-13.9 129 13.9 11.6-16.6 156 11.1 9.4-13.0 224 9.7 8.5-11.1 106 11.5 9.4-13.9 118 8.4 6.9-10.0
2003 268 11.6 10.2-13.1 126 13.7 11.4-16.3 142 10.0 8.4-11.8 209 9.0 7.8-10.3 91 9.9 8.0-12.2 118 8.3 6.9-9.9
2004 292 12.5 11.1-14.0 129 14.0 11.6-16.6 163 11.4 9.7-13.3 236 10.1 8.8-11.5 103 11.2 9.1-13.6 133 9.3 7.8-11.1
2005 277 11.8 10.4-13.3 127 13.6 11.3-16.2 150 10.7 9.1-12.6 199 8.5 7.4-9.8 88 9.4 7.5-11.6 111 7.8 6.4-9.4
2006 314 13.3 11.9-14.9 141 14.9 12.5-17.6 173 12.2 10.4-14.2 232 9.8 8.6-11.2 111 11.9 9.7-14.3 121 8.5 7.1-10.2
2007 317 13.3 11.9-14.9 151 16.3 13.8-19.2 166 11.5 9.8-13.4 250 10.5 9.2-11.9 118 12.7 10.5-15.3 132 9.3 7.8-11.0
2008 323 13.5 12.0-15.0 153 15.8 13.4-18.6 170 11.7 10.0-13.6 254 10.7 9.4-12.1 105 11.1 9.0-13.4 149 10.2 8.6-12.0
2009 344 14.2 12.8-15.8 160 16.6 14.1-19.5 184 12.7 10.9-14.7 257 10.6 9.3-12.0 126 13.0 10.8-15.5 131 8.9 7.5-10.6
2010 371 15.1 13.6-16.7 175 17.0 14.5-19.7 196 13.4 11.6-15.5 266 10.9 9.6-12.3 123 12.2 10.1-14.6 143 9.6 8.1-11.4
2011 347 14.1 12.6-15.7 159 15.6 13.2-18.3 188 12.7 10.9-14.7 298 12.0 10.6-13.4 142 14.1 11.8-16.6 156 10.4 8.8-12.2
2012 387 15.2 13.7-16.8 176 16.6 14.2-19.3 211 14.2 12.3-16.3 308 12.3 10.9-13.7 138 13.3 11.2-15.8 170 11.7 10.0-13.6
2013 360 13.9 12.5-15.5 173 16.4 14.0-19.1 187 12.3 10.5-14.2 277 10.9 9.6-12.2 134 13.1 11.0-15.6 143 9.3 7.8-11.0
2014 339 12.9 11.5-14.3 161 14.6 12.4-17.1 178 11.5 9.9-13.4 260 9.8 8.7-11.1 114 10.4 8.6-12.6 146 9.3 7.9-11.0
2015 381 14.0 12.6-15.5 179 15.3 13.1-17.8 202 12.8 11.0-14.7 285 10.5 9.3-11.8 132 11.6 9.7-13.8 153 9.5 8.0-11.2
2016 370 13.4 12.0-14.9 170 14.4 12.3-16.8 200 12.5 10.8-14.4 265 9.6 8.5-10.9 131 11.0 9.2-13.1 134 8.4 7.0-10.0
2017 413 14.8 13.4-16.3 211 18.1 15.7-20.8 202 12.4 10.7-14.3 297 10.6 9.4-11.9 140 12.3 10.3-14.5 157 9.4 8.0-11.0
2018 393 13.8 12.5-15.3 168 13.8 11.8-16.1 225 13.7 12.0-15.7 299 10.7 9.5-12.0 142 12.2 10.2-14.4 157 9.5 8.0-11.2
2019 382 13.4 12.1-14.9 187 15.4 13.2-17.8 195 11.8 10.2-13.6 262 9.2 8.1-10.4 121 10.1 8.4-12.1 141 8.5 7.1-10.0
2020 365 12.4 11.2-13.8 165 13.1 11.1-15.3 200 12.0 10.4-13.8 288 9.9 8.8-11.1 140 11.7 9.8-13.9 148 8.6 7.3-10.2

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 20 cases or deaths per year are unstable and should be used with caution.
  • Cancer diagnoses trends in 2020 may have been affected by the coronavirus disease 19 (COVID-19) pandemic.
  • The data in this table are not identical to the data in the corresponding 2016-2020 incidence table. See the rationale in 'Considerations When Comparing Cancer Statistics Over Time'.